Shortness of Breath: What Could Be Causing It

What Dyspnea Means and Why It Has So Many Causes

Dyspnea is the medical term for the subjective sensation of breathing difficulty. It is not a disease. It is a symptom that can arise from disruption at any point along the oxygen-delivery chain, from the upper airway to the mitochondria of working muscle. That chain is long, which is why the differential diagnosis list is equally long.

Approximately 25% of patients presenting to primary care report dyspnea as a primary or secondary complaint, according to data published in the American Family Physician review of dyspnea evaluation [1]. The symptom becomes more common with age: prevalence in adults over 70 exceeds 30% in population-based surveys [2]. Because dyspnea can signal conditions as different as panic disorder and aortic stenosis, clinicians approach it systematically by dividing potential causes into organ-system categories.

The major buckets are cardiac, pulmonary, hematologic or metabolic, neuromuscular, and psychogenic. A careful history often narrows the list before a single test is ordered. Onset speed matters. Dyspnea that develops over seconds to minutes points toward pneumothorax, pulmonary embolism (PE), anaphylaxis, or foreign-body aspiration. Dyspnea that worsens over weeks to months suggests heart failure, COPD progression, interstitial lung disease, or anemia. The American Heart Association and the American Thoracic Society both emphasize that dyspnea severity does not reliably correlate with disease severity, making objective testing essential [3].

Cardiac Causes: Heart Failure, Coronary Disease, and Valvular Disorders

Heart failure is the single most common cardiac cause of chronic dyspnea in adults over 50. The heart cannot pump enough blood forward, so fluid backs up into the lungs, producing the classic symptoms of orthopnea (breathlessness when lying flat) and paroxysmal nocturnal dyspnea (waking from sleep gasping).

The AHA estimates that 6.7 million Americans aged 20 and older live with heart failure, a number projected to exceed 8 million by 2030 [4]. In the Framingham Heart Study, dyspnea on exertion was the presenting symptom in 89% of patients eventually diagnosed with heart failure [5]. B-type natriuretic peptide (BNP) testing helps distinguish cardiac from non-cardiac dyspnea in the emergency department. A BNP level above 400 pg/mL has a positive predictive value exceeding 90% for heart failure, while a level below 100 pg/mL effectively rules it out, as demonstrated in the Breathing Not Properly Multinational Study (N=1,586) published in the New England Journal of Medicine [6].

Coronary artery disease can produce exertional dyspnea even without classic chest pain. This presentation, sometimes called an "anginal equivalent," is more common in women, older adults, and patients with diabetes [7]. Valvular heart disease, particularly aortic stenosis and mitral regurgitation, also generates progressive exertional dyspnea. Aortic stenosis affects roughly 2.5% of adults over 75, and once dyspnea develops, median survival without valve replacement drops to approximately two years [8].

Pulmonary Causes: COPD, Asthma, PE, and Interstitial Lung Disease

Lung diseases account for the largest share of dyspnea presentations across all age groups. COPD alone affects an estimated 380 million people globally and is the third leading cause of death worldwide, according to the World Health Organization [9].

COPD-related dyspnea typically presents as progressive exertional breathlessness in a current or former smoker over age 40. Spirometry confirming a post-bronchodilator FEV1/FVC ratio below 0.70 establishes the diagnosis [10]. Asthma, by contrast, tends to cause episodic dyspnea with wheezing and is often accompanied by a history of atopy. The two conditions can overlap. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2024 report estimates that asthma-COPD overlap affects 15 to 20% of patients with obstructive airway disease [10].

Pulmonary embolism deserves special attention because it is both common and dangerous. PE occurs in roughly 5% of patients presenting to the emergency department with acute dyspnea [11]. The PIOPED II study (N=824) found that CT pulmonary angiography has a sensitivity of 83% and specificity of 96% for PE diagnosis [12]. Clinical prediction scores like the Wells criteria and the PERC rule help determine which patients need imaging. A D-dimer level below 500 ng/mL combined with a low clinical probability score effectively excludes PE [11].

Interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF), produces slowly progressive dyspnea with dry cough and fine inspiratory crackles on exam. High-resolution CT of the chest is the key diagnostic tool. IPF carries a median survival of 3 to 5 years from diagnosis, making early referral to a pulmonologist important [13].

Pneumonia causes acute dyspnea with fever, productive cough, and focal lung findings. Community-acquired pneumonia accounts for over 1.5 million emergency department visits annually in the United States [14].

Metabolic and Systemic Causes: Anemia, Obesity, Thyroid Disease, and Deconditioning

Not all dyspnea originates in the heart or lungs. Anemia reduces the oxygen-carrying capacity of blood, and exertional dyspnea typically emerges when hemoglobin falls below 7 to 8 g/dL. Iron-deficiency anemia is the most common type worldwide, affecting roughly 1.2 billion people, according to WHO data published in The Lancet [15].

Obesity causes dyspnea through several mechanisms: increased metabolic demand, reduced chest wall compliance, elevated diaphragm position, and, in severe cases, obesity hypoventilation syndrome. A BMI above 30 kg/m² independently increases the odds of reporting dyspnea by 2.7-fold compared to normal-weight individuals, according to a population-based study in Chest [16]. Dr. Bartolome Celli, a pulmonologist at Brigham and Women's Hospital, has noted: "Obesity-related dyspnea is underdiagnosed because clinicians often attribute the symptom to deconditioning without measuring lung function or considering obesity hypoventilation" [16].

Hyperthyroidism increases basal metabolic rate and cardiac output, which can produce exertional dyspnea and palpitations. Thyroid function testing (TSH, free T4) should be part of the workup when dyspnea lacks an obvious cardiopulmonary explanation [17].

Physical deconditioning is a diagnosis of exclusion. It is real and common, particularly in sedentary older adults, but should only be accepted after cardiac, pulmonary, and hematologic causes have been reasonably excluded.

Anxiety, Panic Disorder, and Hyperventilation Syndrome

Psychogenic dyspnea is a genuine physiological experience, not an imagined one. During a panic attack, sympathetic nervous system activation causes tachypnea, which drives down arterial CO2 and produces the tingling, lightheadedness, and air hunger that patients describe. Hyperventilation syndrome accounts for up to 10% of dyspnea presentations in patients under 40 [18].

Several features suggest psychogenic dyspnea. Symptoms often occur at rest rather than during exertion. Patients frequently describe an inability to take a satisfying deep breath. Symptoms may be accompanied by perioral or fingertip paresthesias from respiratory alkalosis. Pulse oximetry is typically normal or even supranormal.

The diagnosis still requires excluding organic disease. The American Thoracic Society's 2012 consensus statement on dyspnea mechanisms explicitly warns against premature labeling: "Dyspnea attributed to anxiety should remain a diagnosis of exclusion, particularly in patients with risk factors for cardiopulmonary disease" [3]. A chest X-ray, basic metabolic panel, complete blood count, and thyroid panel form a reasonable minimum workup before attributing dyspnea to anxiety alone.

Treatment for hyperventilation syndrome includes cognitive behavioral therapy, controlled breathing techniques, and, in selected cases, SSRI or SNRI medications for underlying anxiety or panic disorder [18].

How Doctors Diagnose the Cause of Shortness of Breath

The diagnostic approach to dyspnea follows a structured sequence. History is the most powerful tool. Clinicians ask about onset speed, duration, triggers, positional variation, associated symptoms (chest pain, cough, leg swelling, fever, weight loss), smoking history, medication use, and occupational exposures.

Physical examination adds data from lung auscultation (wheezes, crackles, absent breath sounds), cardiac exam (murmurs, gallops, jugular venous distension), and peripheral assessment (edema, cyanosis, clubbing). Pulse oximetry is measured immediately.

First-line testing typically includes a chest X-ray, which identifies the cause or narrows the differential in approximately 70% of acute dyspnea presentations [1]. Complete blood count detects anemia. BNP or NT-proBNP helps distinguish cardiac from non-cardiac causes. An electrocardiogram screens for arrhythmia, ischemia, and right heart strain suggestive of PE.

Second-line testing is guided by the initial results. Spirometry is ordered when obstructive or restrictive lung disease is suspected. CT pulmonary angiography is performed when PE probability is intermediate or high. Echocardiography evaluates ventricular function and valvular disease. Arterial blood gas analysis provides precise information about oxygenation, ventilation, and acid-base status [19].

Dr. David Systrom, a cardiopulmonary exercise physiologist at Brigham and Women's Hospital, has stated: "When standard testing fails to explain dyspnea, invasive cardiopulmonary exercise testing can unmask exercise-induced pulmonary hypertension or diastolic dysfunction that resting studies miss entirely" [20]. This advanced testing is reserved for patients with persistent unexplained dyspnea after routine workup.

Red Flags That Require Emergency Evaluation

Certain dyspnea presentations demand immediate medical attention. Call 911 or go to the emergency department for any of the following combinations.

New-onset dyspnea with chest pain or pressure suggests acute coronary syndrome or PE. Sudden dyspnea with unilateral leg swelling raises concern for deep vein thrombosis with PE. Dyspnea with stridor (a high-pitched sound during inhalation) indicates upper airway obstruction from anaphylaxis, angioedema, or foreign body.

Oxygen saturation below 92% on room air at sea level is abnormal and warrants urgent assessment. Dyspnea with altered mental status, hemodynamic instability (systolic blood pressure below 90 mmHg), or cyanosis constitutes a medical emergency regardless of suspected cause [19].

In patients with known heart failure, rapid weight gain of more than 2 kg over 2 to 3 days combined with worsening dyspnea suggests acute decompensation requiring hospitalization and intravenous diuresis [4].

For patients with known COPD, increased sputum volume, sputum color change, and worsening dyspnea together define an acute exacerbation that may require systemic corticosteroids, antibiotics, and possibly hospital admission [10].

Treatment Approaches by Underlying Cause

Treating dyspnea means treating the condition producing it. There is no universal "shortness of breath medication."

For heart failure, guideline-directed medical therapy includes an ACE inhibitor or angiotensin receptor-neprilysin inhibitor (sacubitril/valsartan), a beta-blocker (carvedilol, metoprolol succinate, or bisoprolol), a mineralocorticoid receptor antagonist (spironolactone or eplerenone), and an SGLT2 inhibitor (dapagliflozin or empagliflozin). The DAPA-HF trial (N=4,744) demonstrated that dapagliflozin reduced the composite of worsening heart failure or cardiovascular death by 26% compared with placebo in patients with heart failure with reduced ejection fraction [21].

For COPD, long-acting bronchodilators (tiotropium, umeclidinium, or combined LAMA/LABA inhalers) form the backbone of maintenance therapy. Inhaled corticosteroids are added for patients with frequent exacerbations and elevated blood eosinophil counts above 300 cells/μL [10].

For asthma, inhaled corticosteroid-formoterol combination inhalers used as both maintenance and reliever therapy (the MART approach) have become the preferred strategy in GINA 2023 guidelines for mild-to-moderate disease [22].

For PE, anticoagulation with a direct oral anticoagulant (rivaroxaban or apixaban) is first-line for hemodynamically stable patients. Massive PE with hemodynamic collapse may require systemic thrombolysis with alteplase or catheter-directed therapy [11].

For anemia, treatment depends on the type. Iron-deficiency anemia responds to oral or intravenous iron supplementation. Intravenous ferric carboxymaltose can replete iron stores in one to two infusions, with hemoglobin improvement typically visible within two to four weeks [15].

For obesity-related dyspnea, weight loss through lifestyle modification, GLP-1 receptor agonist therapy, or bariatric surgery can produce measurable improvement. In the STEP-1 trial (N=1,961), semaglutide 2.4 mg weekly produced 14.9% mean body weight loss at 68 weeks versus 2.4% with placebo [23]. Weight loss of 10% or more has been shown to improve both lung function parameters and patient-reported dyspnea scores [16].

Pulmonary rehabilitation, a structured exercise and education program, reduces dyspnea and improves functional capacity in COPD and ILD regardless of disease severity. A Cochrane review of 65 randomized trials confirmed clinically meaningful improvements in dyspnea scores and exercise tolerance with pulmonary rehabilitation [24].

Chronic Dyspnea That Defies Diagnosis

Roughly 15% of patients with chronic dyspnea remain without a clear diagnosis after initial workup [20]. These patients deserve escalation rather than dismissal.

Cardiopulmonary exercise testing (CPET) with gas exchange analysis measures oxygen consumption, carbon dioxide production, and ventilatory efficiency during graded exercise. It can identify exercise-induced diastolic dysfunction, pulmonary vascular disease, mitochondrial myopathy, and ventilatory limitation that resting tests cannot detect.

Invasive CPET, which adds right heart catheterization during exercise, is the gold standard for diagnosing exercise-induced pulmonary hypertension. A study from the Brigham and Women's Dyspnea Center (N=530) found that invasive CPET changed the diagnosis or management in 58% of patients referred for unexplained dyspnea [20].

Dysfunctional breathing patterns, vocal cord dysfunction (now termed inducible laryngeal obstruction), and chronic rhinosinusitis with post-nasal drip are additional causes that standard testing may miss. Laryngoscopy during symptoms can confirm vocal cord dysfunction, which produces inspiratory stridor and dyspnea that mimic refractory asthma [22].

Patients taking GLP-1 receptor agonists or tirzepatide for weight management should be aware that rapid weight loss can unmask previously subclinical cardiac or pulmonary conditions. New or worsening dyspnea during pharmacotherapy warrants reassessment rather than automatic attribution to the medication.